Literature DB >> 15557104

Vessel-specific regulation of angiotensin II receptor subtypes during ovine development.

Blair E Cox1, Xiao-Tie Liu, Steven J Fluharty, Charles R Rosenfeld.   

Abstract

Umbilical and systemic responses to angiotensin II differ in term fetal sheep, and peripheral vascular responses are attenuated or absent before and after birth. These observations may reflect developmental differences in angiotensin II receptor (AT) subtypes in vascular smooth muscle (VSM). Studies of AT subtype ontogeny and regulation are generally limited to the aorta, which may not be extrapolated to other arteries, and neither is completely described during ovine development. We therefore characterized VSM AT subtype expression and regulation throughout an extended period of development in umbilical and carotid artery and aorta from fetal (85-146 d gestation), postnatal (5-23 d), and adult sheep, measuring AT(1) and AT(2) mRNA and protein and performing immunohistochemistry. Parallel increases in umbilical AT(1) mRNA and protein began early in gestation and continued to term, and although AT(2) mRNA was unchanged, protein levels decreased >90% at term. Fetal carotid AT(1) mRNA was <40% of adult values and unchanged before birth; however, AT(1) protein rose >2-fold at term. After birth, AT(1) mRNA increased to 85% of adult values and was associated with another 2-fold rise in protein. In contrast, carotid AT(2) mRNA and protein fell in parallel throughout development and were barely detectable in the newborn and the adult. Immunostaining was consistent with observations in both arteries. A third pattern occurred in aortic VSM. The ontogeny of AT subtype expression and regulation is vessel specific, with changes in umbilical VSM beginning very early in development. Although the mechanisms that regulate mRNA and protein expression are unclear, these changes parallel differences in VSM maturation and function and local blood flow.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15557104     DOI: 10.1203/01.PDR.0000148067.07899.B9

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  6 in total

1.  Defining the differential sensitivity to norepinephrine and angiotensin II in the ovine uterine vasculature.

Authors:  Charles R Rosenfeld; Kevin DeSpain; Xiao-tie Liu
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-10-26       Impact factor: 3.619

2.  Differential sensitivity to angiotensin II and norepinephrine in human uterine arteries.

Authors:  Charles R Rosenfeld; Kevin DeSpain; R Ann Word; Xiao-tie Liu
Journal:  J Clin Endocrinol Metab       Date:  2011-10-26       Impact factor: 5.958

Review 3.  The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target.

Authors:  U Muscha Steckelings; Robert E Widdop; Edward D Sturrock; Lizelle Lubbe; Tahir Hussain; Elena Kaschina; Thomas Unger; Anders Hallberg; Robert M Carey; Colin Sumners
Journal:  Pharmacol Rev       Date:  2022-10       Impact factor: 18.923

4.  Metabolism and synthesis of arginine vasopressin in conscious newborn sheep.

Authors:  Darryl C Miao; Sithembiso C Velaphi; Timothy Roy; Kevin Despain; Charles R Rosenfeld
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-07-08       Impact factor: 4.310

5.  Angiotensin II type 1 receptor blockade partially attenuates hypoxia-induced pulmonary hypertension in newborn piglets: relationship with the nitrergic system.

Authors:  J S Camelo; A R Martins; E Rosa; S G Ramos; D Hehre; E Bancalari; C Suguihara
Journal:  Braz J Med Biol Res       Date:  2012-02-09       Impact factor: 2.590

6.  Angiotensin receptors modulate the renal hemodynamic effects of nitric oxide in conscious newborn lambs.

Authors:  Angela E Vinturache; Francine G Smith
Journal:  Physiol Rep       Date:  2014-05-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.